CLINICAL TRIAL SUMMARY

MDACC Study No:GOG 0264 (clinicaltrials.gov NCT No: NCT01042522)
Title:A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex-Cord Stromal Tumors
Principal Investigator:Jubilee Brown
Treatment Agent:Bleomycin; Carboplatin; Cisplatin; Etoposide; Paclitaxel
Study Status:Open
Study Description:The goal of this clinical research study is to compare the study drug
combination of paclitaxel and carboplatin to the combination of bleomycin,
etoposide, and cisplatin in patients with a malignant stromal tumor of the
ovary. The safety and side effects of the study drug combinations will also be
studied.

Hide details for General InformationGeneral Information

Disease Group:Ovary
Phase of Study:Phase II
Treatment Agents:Bleomycin
Carboplatin
Cisplatin
Etoposide
Paclitaxel
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:Gynecologic Oncology Group
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Jubilee Brown
Dept:Gynecologic Oncology
For Clinical Trial Enrollment:713-792-1380
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults